Esperite N.V. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2012
2013
2014
2015
2016
2017
Sales/Revenue
36,842.00
29,814.00
27,610.00
27,519.00
26,254.00
16,553
Cost of Goods Sold (COGS) incl. D&A
13,017.00
13,402.00
13,321.00
15,460.00
14,526.00
8,440
Gross Income
23,825.00
16,412.00
14,289.00
12,059.00
11,728.00
8,113
SG&A Expense
25,095.00
18,735.00
17,736.00
19,606.00
19,643.00
15,399
EBIT
1,270.00
-
3,447.00
7,547.00
7,915.00
7,286
Unusual Expense
16,213.00
1,131.00
1,658.00
-
987.00
5,550
Non Operating Income/Expense
68.00
92.00
40.00
100.00
11.00
3,121
Interest Expense
196.00
413.00
589.00
572.00
881.00
3,964
Pretax Income
17,298.00
3,459.00
5,408.00
7,856.00
9,468.00
13,546
Income Tax
195.00
31.00
470.00
864.00
1,200.00
18
Equity in Affiliates
-
23.00
67.00
215.00
270.00
681
Consolidated Net Income
17,103.00
3,513.00
5,005.00
7,207.00
8,538.00
12,883
Net Income
17,103.00
3,513.00
5,014.00
7,057.00
8,407.00
12,722
Net Income After Extraordinaries
17,103.00
3,513.00
5,014.00
7,057.00
8,407.00
12,722
Net Income Available to Common
17,103.00
3,513.00
5,014.00
7,057.00
8,407.00
12,722
EPS (Basic)
1.83
0.38
0.51
0.70
0.81
0.93
Basic Shares Outstanding
9,341.40
9,261.30
9,728.70
10,031.40
10,357.50
13,695.40
EPS (Diluted)
1.83
0.38
0.52
0.70
0.81
0.93
Diluted Shares Outstanding
9,343.80
9,261.30
9,728.70
10,031.40
10,357.50
13,659.40
EBITDA
1,944.00
487.00
562.00
4,855.00
4,971.00
4,502
Non-Operating Interest Income
313.00
316.00
326.00
363.00
304.00
133
Minority Interest Expense
-
-
9.00
150.00
131.00
161

About Esperite

View Profile
Address
Herengracht 282
Amsterdam Noord-Holland 1016 BX
Netherlands
Employees -
Website http://www.esperite.com
Updated 07/08/2019
Esperite NV engages in regenerative and predictive medicine. It operates through the following business segments: The extraction and storage of adult human stem cells, Research and Development, Predictive medicine, and Other types of products and services. The extraction and storage of adult human stem cells segment refers to the tem cells collected from the umbilical cord blood, and the umbilical cord itself, at birth and from adipose tissue.